Brokerages Set HealthEquity Inc. (HQY) PT at $34.60
Shares of HealthEquity Inc. (NASDAQ:HQY) have received a consensus recommendation of “Buy” from the nine research firms that are presently covering the stock. Three analysts have rated the stock with a hold rating and six have issued a buy rating on the company. The average 1 year price objective among brokerages that have issued ratings on the stock in the last year is $34.60.
HQY has been the subject of a number of analyst reports. SunTrust Banks Inc. reissued a “buy” rating on shares of HealthEquity in a research report on Thursday, September 8th. Zacks Investment Research raised shares of HealthEquity from a “hold” rating to a “buy” rating and set a $39.00 price objective for the company in a research report on Thursday, September 8th. Wells Fargo & Co. reissued a “buy” rating on shares of HealthEquity in a research report on Wednesday, June 22nd. Robert W. Baird upped their price objective on shares of HealthEquity from $31.00 to $35.00 and gave the company a “neutral” rating in a research report on Wednesday, September 7th. Finally, Raymond James Financial Inc. upped their price objective on shares of HealthEquity from $32.00 to $40.00 and gave the company an “outperform” rating in a research report on Monday, September 12th.
In other HealthEquity news, insider Stephen Neeleman sold 9,898 shares of the firm’s stock in a transaction that occurred on Tuesday, August 23rd. The shares were sold at an average price of $30.28, for a total value of $299,711.44. Following the sale, the insider now owns 9,898 shares in the company, valued at $299,711.44. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, VP Darcy G. Mott sold 10,000 shares of the firm’s stock in a transaction that occurred on Wednesday, July 20th. The shares were sold at an average price of $30.23, for a total transaction of $302,300.00. Following the completion of the sale, the vice president now owns 76,000 shares in the company, valued at approximately $2,297,480. The disclosure for this sale can be found here. Insiders own 29.00% of the company’s stock.
Several large investors have recently made changes to their positions in HQY. Louisiana State Employees Retirement System raised its stake in shares of HealthEquity by 0.6% in the second quarter. Louisiana State Employees Retirement System now owns 15,700 shares of the company’s stock valued at $477,000 after buying an additional 100 shares during the last quarter. Bank of Montreal Can purchased a new stake in shares of HealthEquity during the second quarter valued at approximately $3,295,000. FCM Investments TX raised its stake in shares of HealthEquity by 59.0% in the second quarter. FCM Investments TX now owns 99,701 shares of the company’s stock valued at $3,029,000 after buying an additional 37,001 shares during the last quarter. Capstone Asset Management Co. raised its stake in shares of HealthEquity by 4.7% in the second quarter. Capstone Asset Management Co. now owns 10,700 shares of the company’s stock valued at $325,000 after buying an additional 480 shares during the last quarter. Finally, BNP Paribas Arbitrage SA raised its stake in shares of HealthEquity by 0.7% in the second quarter. BNP Paribas Arbitrage SA now owns 44,898 shares of the company’s stock valued at $1,364,000 after buying an additional 321 shares during the last quarter. Institutional investors own 90.54% of the company’s stock.
Shares of HealthEquity (NASDAQ:HQY) opened at 36.75 on Thursday. The stock’s 50 day moving average price is $35.73 and its 200-day moving average price is $29.64. HealthEquity has a 52-week low of $15.80 and a 52-week high of $38.80. The firm has a market cap of $2.16 billion, a PE ratio of 94.23 and a beta of 1.61.
HealthEquity (NASDAQ:HQY) last announced its quarterly earnings results on Tuesday, September 6th. The company reported $0.16 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.13 by $0.03. HealthEquity had a return on equity of 10.89% and a net margin of 15.21%. The firm earned $44.20 million during the quarter. During the same quarter in the prior year, the company posted $0.08 earnings per share. The firm’s revenue for the quarter was up 44.9% on a year-over-year basis. On average, equities research analysts anticipate that HealthEquity will post $0.51 earnings per share for the current fiscal year.
HealthEquity Company Profile
HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.
Receive News & Stock Ratings for HealthEquity Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity Inc. and related stocks with our FREE daily email newsletter.